Generex goes up a few cents so now we have to listen to this garbage again...

"Also attracted to the diabetic area was Alfred Mann, the head of MannKind (MNKD). MannKind also went the lung absorption route. In their case, they have pursued this approach long after Pfizer put the kibosh on their program, and Novo Nordisk dropped out. Is this block-headedness taken to the power of x? Or is this stubbornness that finally wins in the end? My bet is on consumers - they don't want to put stuff in their lungs. I wouldn't, especially if there were a less offensive way of getting the insulin. And there is."

http://seekingalpha.com/article/1145681-generex-research-for-sale-on-the-cheap?source=google_news